Neurokinin antagonist - TAP Pharmaceutical Products
Latest Information Update: 03 Apr 2007
At a glance
- Originator TAP Pharmaceutical Products
- Class
- Mechanism of Action Tachykinin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Irritable bowel syndrome; Major depressive disorder; Urinary incontinence
Most Recent Events
- 09 Jan 2002 Phase-II clinical trials for Depression in USA (Unknown route)
- 09 Jan 2002 Phase-II clinical trials for Irritable bowel syndrome in USA (Unknown route)
- 09 Jan 2002 Phase-II clinical trials for Urinary incontinence in USA (Unknown route)